Meury William
SEC insider (Form 3/4/5 filer). CIK 0001536778. Chief Executive Officer at INCYTE CORP (INCY) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Jul 16, 2026. Located in WILMINGTON, DE.
Companies Meury William has filed insider reports for
- INCYTE CORP (INCY): Director, Officer, Chief Executive Officer
- Syndax Pharmaceuticals Inc (SNDX): Director
Meury William
CIK: 0001536778
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)1 (16.7%)
Derivative conversions
Awards (A)4 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)1 (16.7%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jul 16, 2026INCY
INCYTE CORP
AwardDirect26.8K shares- - Jul 2, 2026INCY
INCYTE CORP
Tax PaymentDirect4.8K shares at avg. $116.86$558K - Apr 15, 2026INCY
INCYTE CORP
ExerciseDirect125K shares- - Jul 2, 2025INCY
INCYTE CORP
AwardDirect36.1K shares- - Jun 26, 2025INCY
INCYTE CORP
AwardDirectEmployee Stock Option (right to buy)
110.6K shares- - Feb 5, 2025SNDX
Syndax Pharmaceuticals Inc
AwardDirect25K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 16, 2026 |  INCY INCYTE CORP | Award | 26,807 | - | $0 | Direct |
| Jul 2, 2026 | INCY INCYTE CORP | Tax Payment | 4,779 | $116.86 | $558,474 | Direct |
| Apr 15, 2026 | INCY INCYTE CORP | Exercise | 125,000 | - | $0 | Direct |
| Jul 2, 2025 | INCY INCYTE CORP | Award | 36,101 | - | - | Direct |
| Jun 26, 2025 | INCY INCYTE CORP | Award Employee Stock Option (right to buy) | 110,630 | - | - | Direct |
| Feb 5, 2025 |  SNDX Syndax Pharmaceuticals Inc | Award | 25,000 | - | - | Direct |
1-6 of 6 transactions